Prospective comparative trial of moxalactam versus ampicillin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis in children.
In a prospective, randomized study, moxalactam in 44 children was compared with ampicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P less than or equal to 0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.
D000667:Ampicillin / Q000008:administration & dosage* / Q000009:adverse effects; D001772:Blood Cell Count; D002675:Child, Preschool; D002701:Chloramphenicol / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006193:Haemophilus influenzae / Q000187:drug effects; D006319:Hearing Loss, Sensorineural / Q000209:etiology; D006801:Humans; D007223:Infant; D008583:Meningitis, Haemophilus / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy*; D009070:Moxalactam / Q000008:administration & dosage* / Q000009:adverse effects; D010403:Penicillin Resistance; D011446:Prospective Studies
D002701:Chloramphenicol; D000667:Ampicillin; D009070:Moxalactam